Prognostic role of genetic biomarkers in clinical progression of prostate cancer

The aim of this study was to analyze the use of 12 single-nucleotide polymorphisms in genes ELAC2, RNASEL and MSR1 as biomarkers for prostate cancer (PCa) detection and progression, as well as perform a genetic classification of high-risk patients. A cohort of 451 men (235 patients and 216 controls)...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Exp Mol Med
Auteurs principaux: Alvarez-Cubero, Maria Jesus, Martinez-Gonzalez, Luis Javier, Saiz, Maria, Carmona-Saez, Pedro, Alvarez, Juan Carlos, Pascual-Geler, Manrique, Lorente, Jose Antonio, Cozar, Jose Manuel
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2015
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4558485/
https://ncbi.nlm.nih.gov/pubmed/26251261
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/emm.2015.43
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires